<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Namavar Y</submitter><funding>Manchester NIHR Biomedical Research Centre</funding><funding>Medical Research Council</funding><funding>Hersenstichting Nederland</funding><funding>NINDS NIH HHS</funding><funding>AMC Graduate School, University of Amsterdam</funding><funding>NIH</funding><pagination>143-56</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC9136852</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>134(Pt 1)</volume><pubmed_abstract>Pontocerebellar hypoplasia is a group of autosomal recessive neurodegenerative disorders with prenatal onset. The common characteristics are cerebellar hypoplasia with variable atrophy of the cerebellum and the ventral pons. Supratentorial involvement is reflected by variable neocortical atrophy, ventriculomegaly and microcephaly. Mutations in the transfer RNA splicing endonuclease subunit genes (TSEN54, TSEN2, TSEN34) were found to be associated with pontocerebellar hypoplasia types 2 and 4. Mutations in the mitochondrial transfer RNA arginyl synthetase gene (RARS2) were associated with pontocerebellar hypoplasia type 6. We studied a cohort of 169 patients from 141 families for mutations in these genes, of whom 106 patients tested positive for mutations in one of the TSEN genes or the RAR</pubmed_abstract><journal>Brain : a journal of neurology</journal><pubmed_title>Clinical, neuroradiological and genetic findings in pontocerebellar hypoplasia.</pubmed_title><pmcid>PMC9136852</pmcid><funding_grant_id>KS2009(1)-81</funding_grant_id><funding_grant_id>G0601943</funding_grant_id><funding_grant_id>R01 NS050375</funding_grant_id><pubmed_authors>Ventura K</pubmed_authors><pubmed_authors>von Moers A</pubmed_authors><pubmed_authors>Seidl R</pubmed_authors><pubmed_authors>Wargowski D</pubmed_authors><pubmed_authors>Sival DA</pubmed_authors><pubmed_authors>Kyllerman M</pubmed_authors><pubmed_authors>Gooskens R</pubmed_authors><pubmed_authors>Phillips JJ</pubmed_authors><pubmed_authors>Freeman JL</pubmed_authors><pubmed_authors>Hageman G</pubmed_authors><pubmed_authors>PCH Consortium</pubmed_authors><pubmed_authors>Baas F</pubmed_authors><pubmed_authors>Foulds N</pubmed_authors><pubmed_authors>Kress W</pubmed_authors><pubmed_authors>Writzl K</pubmed_authors><pubmed_authors>Boycott K</pubmed_authors><pubmed_authors>Ades LC</pubmed_authors><pubmed_authors>Eason J</pubmed_authors><pubmed_authors>Eggens VR</pubmed_authors><pubmed_authors>Ouvrier R</pubmed_authors><pubmed_authors>van der Knaap MS</pubmed_authors><pubmed_authors>Mollmann S</pubmed_authors><pubmed_authors>Tijssen MA</pubmed_authors><pubmed_authors>Brussel W</pubmed_authors><pubmed_authors>Rutledge JC</pubmed_authors><pubmed_authors>Haeussler M</pubmed_authors><pubmed_authors>Nemeth AH</pubmed_authors><pubmed_authors>Horn D</pubmed_authors><pubmed_authors>Dobyns WB</pubmed_authors><pubmed_authors>Brueton L</pubmed_authors><pubmed_authors>Chandler KE</pubmed_authors><pubmed_authors>Isidor B</pubmed_authors><pubmed_authors>Ryan MM</pubmed_authors><pubmed_authors>Snoeck IN</pubmed_authors><pubmed_authors>Straussberg R</pubmed_authors><pubmed_authors>Fisher RB</pubmed_authors><pubmed_authors>Debus O</pubmed_authors><pubmed_authors>Shannon NL</pubmed_authors><pubmed_authors>van Ruissen F</pubmed_authors><pubmed_authors>Bernert G</pubmed_authors><pubmed_authors>Namavar Y</pubmed_authors><pubmed_authors>Van der Aa N</pubmed_authors><pubmed_authors>Roelens F</pubmed_authors><pubmed_authors>Williams AN</pubmed_authors><pubmed_authors>Demir E</pubmed_authors><pubmed_authors>Lunsing RJ</pubmed_authors><pubmed_authors>McGillivray G</pubmed_authors><pubmed_authors>Poll-The BT</pubmed_authors><pubmed_authors>Arts WF</pubmed_authors><pubmed_authors>Krageloh-Mann I</pubmed_authors><pubmed_authors>King M</pubmed_authors><pubmed_authors>Cowan FM</pubmed_authors><pubmed_authors>Basel-Vanagaite L</pubmed_authors><pubmed_authors>Brockmann K</pubmed_authors><pubmed_authors>Hammersen G</pubmed_authors><pubmed_authors>Sellerer NC</pubmed_authors><pubmed_authors>Palmafy B</pubmed_authors><pubmed_authors>Knoers N</pubmed_authors><pubmed_authors>Korinthenberg R</pubmed_authors><pubmed_authors>Neufeld-Kaiser W</pubmed_authors><pubmed_authors>Bahi-Buisson N</pubmed_authors><pubmed_authors>Battini R</pubmed_authors><pubmed_authors>Lachmeijer AM</pubmed_authors><pubmed_authors>Windpassinger C</pubmed_authors><pubmed_authors>Kroisel PM</pubmed_authors><pubmed_authors>Peeters EA</pubmed_authors><pubmed_authors>Kasher PR</pubmed_authors><pubmed_authors>Muntoni F</pubmed_authors><pubmed_authors>Price S</pubmed_authors><pubmed_authors>De Meirleir L</pubmed_authors><pubmed_authors>Verloo P</pubmed_authors><pubmed_authors>Ferriero DM</pubmed_authors><pubmed_authors>de Vries LS</pubmed_authors><pubmed_authors>Barth PG</pubmed_authors><pubmed_authors>Bodamer O</pubmed_authors><pubmed_authors>de Rijk-van Andel JF</pubmed_authors><pubmed_authors>Cheng EY</pubmed_authors><pubmed_authors>Boltshauser E</pubmed_authors><pubmed_authors>Ferrie CD</pubmed_authors><pubmed_authors>Hastanesi G</pubmed_authors><pubmed_authors>Sztriha L</pubmed_authors><pubmed_authors>van Nieuwenhuizen O</pubmed_authors><pubmed_authors>Regal L</pubmed_authors><pubmed_authors>Graham JM</pubmed_authors><pubmed_authors>Rankin J</pubmed_authors><pubmed_authors>Crow Y</pubmed_authors></additional><is_claimable>false</is_claimable><name>Clinical, neuroradiological and genetic findings in pontocerebellar hypoplasia.</name><description>Pontocerebellar hypoplasia is a group of autosomal recessive neurodegenerative disorders with prenatal onset. The common characteristics are cerebellar hypoplasia with variable atrophy of the cerebellum and the ventral pons. Supratentorial involvement is reflected by variable neocortical atrophy, ventriculomegaly and microcephaly. Mutations in the transfer RNA splicing endonuclease subunit genes (TSEN54, TSEN2, TSEN34) were found to be associated with pontocerebellar hypoplasia types 2 and 4. Mutations in the mitochondrial transfer RNA arginyl synthetase gene (RARS2) were associated with pontocerebellar hypoplasia type 6. We studied a cohort of 169 patients from 141 families for mutations in these genes, of whom 106 patients tested positive for mutations in one of the TSEN genes or the RAR</description><dates><release>2011-01-01T00:00:00Z</release><publication>2011 Jan</publication><modification>2026-04-08T10:36:01.509Z</modification><creation>2025-04-07T08:26:27.947Z</creation></dates><accession>S-EPMC9136852</accession><cross_references><pubmed>20952379</pubmed><doi>10.1093/brain/awq287</doi></cross_references></HashMap>